[VRDN] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 4.97%
YoY- -99.57%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 72 98 105 1,195 256 216 214 -51.72%
PBT -55,063 -68,151 -45,785 -28,905 -29,491 -25,693 -28,946 53.70%
Tax 4,378 -105 -3,281 -880 227 -196 3 12938.61%
NP -55,063 -68,046 -42,504 -28,025 -29,491 -25,497 -28,946 53.70%
Tax Rate - - - - - - - -
Total Cost 55,135 68,144 42,609 29,220 29,747 25,713 29,160 53.08%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -76,476.39 -69,434.69 -40,480.00 -2,345.19 -11,519.92 -11,804.17 -13,526.17 218.38%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.27 -1.61 -1.05 -0.83 -1.06 -0.98 -2.59 -37.89%
EPS Diluted -1.27 -1.61 -1.05 -0.83 -1.06 -0.98 -2.59 -37.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.